Study of Magnetic Resonance Image and Computed Tomography-Guided Stereotactic Body Radiation Therapy for Abdominopelvic Sarcomas (MARS Trial)

Recent advances in radiation treatment have allowed for higher doses per treatment to be delivered safely. This study plans to use an MRI-guided linear accelerator to deliver the radiation treatment to ensure that the radiation dose is administered to the cancerous tumor, not the vital body organs. Potential participants with a sarcoma diagnosis will be referred to Radiation Oncology during this study. If the participant is interested in participating in this study, s/he receives radiation treatment daily for 5 consecutive days except for weekends and holidays. Within 12 weeks of completing t

Trial Details

NCT ID

NCT06436612

Phase

PHASE2

Sponsor

Jonsson Comprehensive Cancer Center

Status

RECRUITING

Cancer Type

Sarcoma

Interventions

• Magnetic Resonance Image and Computed Tomography-Guided Stereotactic Body Radiation Therapy

Locations (sample)

• Los Angeles, California, United States|34.05223,-118.24368

Key Eligibility Criteria

• Histologically confirmed sarcoma
• Primary or recurrent disease involving the abdomen or pelvis
• Resectable primary lesion
• Age ≥ 12 years old

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Sarcoma Trials on Trialify →